LATE-BREAKING ABSTRACT: Glycopyrronium once-daily significantly improves lung function and health status when added to fluticasone/salmeterol in patients with COPD: The GLISTEN study
P. Frith, R. Ratnavadivel, P. Thompson, P. Bremner, C. L Chang, P. Day, C. Frenzel, N. Kurstjens, A. T. G. S. G. (Adelaide, Gosford, Perth, Brisbane, Sydney, Australia; Hamilton, New Zealand)
Source: International Congress 2014 – Latest insights in airway diseases
Session: Latest insights in airway diseases
Session type: Thematic Poster Session
Number: 2811
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Frith, R. Ratnavadivel, P. Thompson, P. Bremner, C. L Chang, P. Day, C. Frenzel, N. Kurstjens, A. T. G. S. G. (Adelaide, Gosford, Perth, Brisbane, Sydney, Australia; Hamilton, New Zealand). LATE-BREAKING ABSTRACT: Glycopyrronium once-daily significantly improves lung function and health status when added to fluticasone/salmeterol in patients with COPD: The GLISTEN study. Eur Respir J 2014; 44: Suppl. 58, 2811
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: